C4 Therapeutics, Inc.
CCCC
$4.24
$0.163.92%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 253.66M | 235.67M | 248.54M | 191.88M | 214.55M |
| Total Receivables | 1.33M | 2.88M | 2.40M | 6.54M | 2.16M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.91M | 6.82M | 7.17M | 8.44M | 8.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 262.90M | 245.37M | 258.11M | 206.86M | 224.73M |
|
|
|||||
| Total Current Assets | 262.90M | 245.37M | 258.11M | 206.86M | 224.73M |
| Net Property, Plant & Equipment | 41.79M | 43.58M | 45.28M | 47.10M | 59.76M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.93M | 7.31M | 7.13M | 3.65M | 3.62M |
| Total Assets | 359.40M | 328.86M | 359.08M | 265.49M | 296.53M |
|
|
|||||
| Total Accounts Payable | 1.12M | 773.00K | 858.00K | 1.33M | 2.22M |
| Total Accrued Expenses | 12.79M | 8.26M | 11.92M | 9.52M | 11.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.68M | 6.52M | 6.37M | 6.22M | 6.07M |
| Total Finance Division Other Current Liabilities | 27.66M | 11.70M | 13.89M | 18.88M | 24.20M |
| Total Other Current Liabilities | 27.66M | 11.70M | 13.89M | 18.88M | 24.20M |
| Total Current Liabilities | 48.25M | 27.25M | 33.03M | 35.95M | 44.46M |
|
|
|||||
| Total Current Liabilities | 48.25M | 27.25M | 33.03M | 35.95M | 44.46M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 50.18M | 51.93M | 53.62M | 55.25M | 56.86M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.71M | 15.44M | 15.84M | 19.89M | 21.15M |
| Total Liabilities | 112.14M | 94.61M | 102.49M | 111.08M | 122.46M |
|
|
|||||
| Common Stock & APIC | 1.04B | 998.39M | 995.23M | 872.53M | 860.14M |
| Retained Earnings | -787.46M | -763.82M | -738.69M | -718.21M | -686.04M |
| Treasury Stock & Other | -444.00K | -322.00K | 50.00K | 87.00K | -30.00K |
| Total Common Equity | 247.27M | 234.25M | 256.59M | 154.41M | 174.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 247.27M | 234.25M | 256.59M | 154.41M | 174.06M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 247.27M | 234.25M | 256.59M | 154.41M | 174.06M |
|
|
|||||